Ezzyat, Youssef
Wanda, Paul A.
Levy, Deborah F.
Kadel, Allison
Aka, Ada
Pedisich, Isaac
Sperling, Michael R.
Sharan, Ashwini D.
Lega, Bradley C.
Burks, Alexis
Gross, Robert E.
Inman, Cory S.
Jobst, Barbara C.
Gorenstein, Mark A.
Davis, Kathryn A.
Worrell, Gregory A.
Kucewicz, Michal T.
Stein, Joel M.
Gorniak, Richard
Das, Sandhitsu R.
Rizzuto, Daniel S.
Kahana, Michael J.
Article History
Received: 11 September 2017
Accepted: 20 December 2017
First Online: 6 February 2018
Competing interests
: B.C.J. receives research funding from NeuroPace and Medtronic not relating to this research. M.J.K. and D.S.R. are in the process of organizing Nia Therapeutics, LLC (“Nia”), a company intended to develop and commercialize brain stimulation therapies for memory restoration. Currently, Nia has no assets and has not commenced operations. M.J.K. and D.S.R. each holds a greater than 5% equity interest in Nia. All other authors declare no competing financial interests.